Company Collaborates With Internationally Renowned Tumor Immunologists for Novel Immune Based Therapy OCEANSIDE, CA–(Marketwired – Nov 23, 2015) – Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today a patent for developing a future generation of immune cell derived nanoparticles, termed ...
Read More »Anti-cancer drug docosahexaenoic acid (DHA) alters breast cancer exosome secretion and microRNA contents
Docosahexaenoic acid (DHA) is a natural compound with anticancer and anti-angiogenesis activity that is currently under investigation as both a preventative agent and an adjuvant to breast cancer therapy. However, the precise mechanisms of DHA’s anticancer activities are unclear. It ...
Read More »